Growing healthcare industry in developing countries of Asia Pacific creates better opportunities for market players to expand their business. The huge patient population in emerging countries is generating demand for advanced diagnostic systems.

According to a new market research study of ‘Creatinine Measurement Market to 2027 – Global Analysis and Forecasts by Product, Type, Sample Type, and End User.’ The global creatinine measurement market is expected to reach US$ 705.96 Mn in 2027 from US$ 384.69 Mn in 2019. The market is estimated to grow with a CAGR of 8.0% from 2020-2027. The report provides trends prevailing in the global creatinine measurement market and the factors driving market along with those that act as hindrances.

Get Your Free Sample Copy Today | Click Here: https://www.theinsightpartners.com/sample/TIPBT00002180

For instance, according to the global burden of disease data, India has 18% of the world’s population; however, the country holds about 17% of the global burden of kidney diseases. Additionally, an increasing number of dialysis procedures represent the massive growth in the prevalence of renal diseases. Furthermore, according to estimates published by the Global Burden of Disease, China alone has 119.5 million renal disease patients. Thus, rapidly growing incidence of kidney diseases coupled with the demand–supply gap in diagnostic tests is projected to offer lucrative opportunities for growth of the market by 2027.

The global creatinine measurement market, based on sample type, was segmented as blood or serum and urine. In 2019, the blood or serum segment accounted for the largest market share in the global creatinine measurement market. Additionally this segment is expected to grow at faster pace in the forecasted period as well. The growth of the blood or serum segment is expected to grow because blood creatinine levels are measured as a test of kidney function and in case of kidney impairment, the creatinine levels in blood increase as a result of poor removal of this substance by kidneys. Additionally, most of the commercially available creatinine measurement kits recommend blood samples owing to its accuracy of outcomes obtained and low risk of sample contamination

Leading companies operating in the creatinine measurement market are Siemens Healthcare Gmbh, Abbott, Cayman Chemical, Thermo Fisher Scientific Inc., Fujifilm Wako Pure Chemical Corporation, Randox Laboratories Ltd, F. Hoffmann-La Roche Ltd, Danaher (Beckman Coulter), Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Maccura Biotechnology Co., Ltd, Diazyme Laboratories, Inc., Dialab GMBH, Beijing Jiuqiang Biotechnology Co., Ltd. Beijing Leadman Biochemistry, Fosun Pharmaceutical among others.

Global Creatinine Measurement Market – By Product

•          Reagents

•          Kits

Global Creatinine Measurement Market – By Type

•          Jaffe’s Kinetic Method

•          Enzymatic Method

Global Creatinine Measurement Market – By Sample Type

•          Blood or Plasma

•          Urine

Global Creatinine Measurement Market – By End User

•          Hospitals

•          Diagnostic Laboratories

•          Others

About US

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Creatinine Measurement, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

Contact US

Contact Person : Ankit Mathur

Phone : +1-646-491-9876

E-mail : [email protected]